Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Review (2022)

Authors

Jun Toyohara Tokyo Metropolitan Institute of Gerontology, Tokyo
Mohammed Al-Qahtani King Faisal Specialist Hospital and Research Centre
Ya Yao Huang National Taiwan University
Emiliano Cazzola Sacro Cuore-Don Calabria Hospital, Negrar
Sergio Todde Università degli Studi di Milano Bicocca
Shozo Furumoto Tohoku University
Renata Mikolajczak National Centre for Nuclear Research (NCBJ), Otwock
A.G. Denkova RST/Applied Radiation & Isotopes - AS
Y. Seimbille Erasmus MC
Research Group
RST/Applied Radiation & Isotopes (AS) (TU Delft)
Copyright: © 2022 Jun Toyohara, Mohammed Al-Qahtani, Ya Yao Huang, Emiliano Cazzola, Sergio Todde, Shozo Furumoto, Renata Mikolajczak, A.G. Denkova, Y. Seimbille
DOI: https://doi.org/10.1186/s41181-022-00177-w
More Info
expand_more

Published Date

2022

Language

English

Faculty

Applied Sciences

Department

RST/Radiation, Science and Technology

Research Group

RST/Applied Radiation & Isotopes

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.